Home › NDC Lookup › RxCUI directory › RxCUI 2612681

0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli] — RxCUI 2612681

Name: 0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli] (RxCUI 2612681)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2612681 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2612681

Official name0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asCimerli 0.3 MG per 0.05 ML Injection; CIMERLI 0.3 MG in 0.05 ML Injection; Cimerli 6 MG/ML per 0.05 ML Injection

FDA products mapped4

Package NDCs mapped4

Reported Medicaid activity (SDUD)4,931 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ranibizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's blocking a protein called VEGF-A that tells blood vessels in your eye to grow in abnormal ways and leak fluid — both of which can damage your retina and blur your vision. By b...
What exactly is ranibizumab doing inside my eye?
Both contain ranibizumab, but they're delivered differently. Lucentis is given as a direct injection into the eye on a schedule your doctor sets. Susvimo is a small implant surgica...
What's the difference between Lucentis and Susvimo?

📖 Read our full Ranibizumab Injection guide →

🕸️ Concept Web — How 0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cime... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.05 ML ranibizumab-eqrn 6 MG/ML Injection [Cimerli] RxCUI 2612681 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Ranibizumab 595060 IN
- Ranibizumab-eqrn 2612673 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Cimerli 2612677 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ranibizumab Injection 1724210 SCDF
- Ranibizumab-eqrn Injection 2646157 SCDFP
- Ranibizumab Injectable Product 1157901 SCDG
- Ranibizumab-eqrn Injectable Product 2659217 SCDGP
- Ranibizumab Injection [Cimerli] 2612680 SBDF
- Ranibizumab-eqrn Injection [Cimerli] 2656342 SBDFP
- Cimerli Injectable Product 2612679 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.05 ML ranibizumab-eqrn 6 MG/ML Injection 2612675 SCD
- Ranibizumab-eqrn 6 MG/ML 2612674 SCDC
- Ranibizumab-eqrn 6 MG/ML [Cimerli] 2612678 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.05 ML ranibizumab-eqrn 6 MG/ML Injection SCD · 2612675
Ranibizumab-eqrn 6 MG/ML SCDC · 2612674
Ranibizumab Injection SCDF · 1724210
Ranibizumab-eqrn Injection SCDFP · 2646157
Ranibizumab Injectable Product SCDG · 1157901
Ranibizumab-eqrn Injectable Product SCDGP · 2659217

Brand-Name Concepts

Ranibizumab-eqrn 6 MG/ML [Cimerli] SBDC · 2612678
Ranibizumab Injection [Cimerli] SBDF · 2612680
Ranibizumab-eqrn Injection [Cimerli] SBDFP · 2656342
Cimerli Injectable Product SBDG · 2612679
Cimerli BN · 2612677

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 2612681 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61314-0624-94	1 VIAL, SINGLE-DOSE in 1 CARTON (61314-624-94) / .05 mL in...	CIMERLI	Sandoz Inc	2024-12-12
61314-0625-94	1 VIAL, SINGLE-DOSE in 1 CARTON (61314-625-94) / .05 mL in...	CIMERLI	Sandoz Inc	2024-12-12
70114-0440-01	1 VIAL, SINGLE-DOSE in 1 CARTON (70114-440-01) / .05 mL in...	CIMERLI	Coherus BioSciences Inc	2022-10-03
70114-0441-01	1 VIAL, SINGLE-DOSE in 1 CARTON (70114-441-01) / .05 mL in...	CIMERLI	Coherus BioSciences Inc	2022-10-03

Observed labelers: Coherus BioSciences Inc (2) · Sandoz Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5128	Inj, cimerli, 0.1 mg	4	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.